Latest Intelligence

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
NewsWire
NewsWire

Insys signs sub-license agreement with Gold Coast for treatment of CP/CPPS

Insys Therapeutics, Inc., a specialty pharmaceutical company, has signed an exclusive sub-license agreement with Gold Coast Therapeutics, to develop a combination of Cromolyn Sodium and Cetirizine as a new chemical entity for the treatment of chronic prostatitis/chronic pelvic pain syndrome, or CP/CPPS.

Published By MarketLine
02 Mar 2015
NewsWire
NewsWire

Kaneka and Okayama Barley sign licensing agreement for GSSG technology

Kaneka Corporation, a chemical company, and Okayama Barley Genome Technology Co. Ltd. have signed an inclusive licensing agreement for the invention of oxidized glutathione, or GSSG, technology in the field of agriculture.

Published By MarketLine
02 Mar 2015
NewsWire
NewsWire

MyPoints.com unveils new Swappable mobile app

MyPoints.com, Inc., a subsidiary of United Online, Inc., has announced the launch of Swappable, a mobile app available on both the App Store and Google Play, which allows users to purchase, share, personalize and swap gift cards from merchants.

Published By MarketLine
02 Mar 2015
NewsWire
NewsWire

Glenmark announces approval and launch of oral contraceptive tablets in US

Glenmark Generics Inc., USA, the subsidiary of Glenmark Generics Limited, has announced the US market approval and launch of Ashlyna extended-cycle oral contraceptive tablets.

Published By MarketLine
02 Mar 2015
NewsWire
NewsWire

Miu Miu opens new store in Sanya, South China

Miu Miu, a fashion brand of women's clothing and accessories from the Prada fashion house, has opened a new store in the city of Sanya, South China.

Published By MarketLine
02 Mar 2015
NewsWire
NewsWire

Jubilant's ANDA for hypertension and allergy drugs receives FDA approval

Jubilant Life Sciences Ltd has received FDA approval for abbreviated new drug application, or ANDA, of Irbesartan Tablets USP, 75mg, 150mg, and 300mg and Cetirizine Hydrochloride Tablets Chewable, 5mg and 10mg.

Published By MarketLine
02 Mar 2015
NewsWire
NewsWire

Curis Q4 net loss up

Curis, Inc., a biotechnology company, has reported that net loss for the fourth quarter ended December 31, 2014 was $5.69 million, or $0.07 loss per share, compared to a net loss of $4.2 million, or $0.05 loss per share, for the same quarter ended December 31, 2013.

Published By MarketLine
02 Mar 2015
NewsWire
NewsWire

Kimberly-Clark announces retirement of CFO

Kimberly-Clark Corporation, an American personal care corporation, has announced that CFO Mark Buthman, has announced his intention to retire at the end of 2015.

Published By MarketLine
02 Mar 2015
NewsWire
NewsWire

BBVA names market president for Upper Rio Grande Valley

BBVA Compass Bancshares, Inc. has named Jason Leal as market president of the Upper Rio Grande Valley.

Published By MarketLine
02 Mar 2015
NewsWire
NewsWire

Xerox launches two new printers

Xerox Corporation Ltd., an American document management company, has launched the Phaser 6022 color printer and WorkCentre 6027 color multifunction printer, or MFP.

Published By MarketLine
02 Mar 2015

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.